Effects of nicorandil on QT prolongation and myocardial damage caused by citalopram in rats

References

• Abdel‐Raheem IT, Taye A, Abouzied MM. 2013. Cardioprotective effects of nicorandil, a mitochondrial potassium channel opener against doxorubicin‐induced cardiotoxicity in rats. Basic Clin Pharmacol Toxicol. 113:158–166. doi: 10.1111/bcpt.12078.
   PubMed Web of Science ®Google Scholar
• Afzal MZ, Reiter M, Gastonguay C, McGivern JV, Guan X, Ge Z-D, Mack DL, Childers MK, Ebert AD, Strande JL. 2016. Nicorandil, a nitric oxide donor and ATP-sensitive potassium channel opener, protects against dystrophin-deficient cardiomyopathy. J Cardiovasc Pharmacol Ther. 21:549–562. doi: 10.1177/1074248416636477.
   PubMed Web of Science ®Google Scholar
• Ahmadian E, Eftekhari A, Fard JK, Babaei H, Nayebi AM, Mohammadnejad D, Eghbal MA. 2017. In vitro and in vivo evaluation of the mechanisms of citalopram-induced hepatotoxicity. Arch Pharm Res. 40:1296–1313. doi: 10.1007/s12272-016-0766-0.
   PubMed Web of Science ®Google Scholar
• Ahmed LA. 2019. Nicorandil: a drug with ongoing benefits and different mechanisms in various diseased conditions. Ind J Pharmacol. 51:296–301. doi: 10.4103/ijp.IJP_298_19.
   Google Scholar
• Ahmed LA, El-Maraghy SA. 2013. Nicorandil ameliorates mitochondrial dysfunction in doxorubicin-induced heart failure in rats: possible mechanism of cardioprotection. Biochem Pharmacol. 86:1301–1310. doi: 10.1016/j.bcp.2013.07.005.
   PubMed Web of Science ®Google Scholar
• Akagi T, Sarazawa K, Inai Y, Kitagawa M, Takahashi N, Hamanaka I, Yamazaki T, Takebe M, Hama N, Hiraoka Y, Ueda K, Nakazawa K, Matsumoto N. 2006. Continuous administration of nicorandil decreases QT dispersion during the chronic phase of acute myocardial infarction. Int Heart J. 47:351–361. doi: 10.1536/ihj.47.351.
   PubMed Web of Science ®Google Scholar
• Aktürk G, Kalkan Ş. 2019. Drug-induced QT interval prolongation: mechanisms, risk factors, genetics and clinical management. J Basic Clin Health Sci. 3:193–198. doi: 10.30621/jbachs.2019.712.
   Web of Science ®Google Scholar
• Álvarez E, Vieira S, Garcia-Moll X. 2014. Citalopram, escitalopram and prolonged QT: warning or alarm? Rev Psiquiat Salud Ment. 7:147–150. doi: 10.1016/j.rpsm.2013.12.005.
   Google Scholar
• Asensio-López MC, Soler F, Pascual-Figal D, Fernández-Belda F, Lax A, Bachschmid MM. 2017. Doxorubicin-induced oxidative stress: the protective effect of nicorandil on HL-1 cardiomyocytes. PLoS One. 12:e0172803. doi: 10.1371/journal.pone.0172803.
   PubMed Web of Science ®Google Scholar
• Barbey JT, Roose SP. 1998. SSRI safety in overdose. J Clin Psych. 59:42–48.
   Google Scholar
• Beaune S, Callebert J, Baud FJ, Risède P, Juvin P, Mégarbane B. 2012. Mechanisms of high-dose citalopram-induced death in a rat model. Toxicology. 302:248–254. doi: 10.1016/j.tox.2012.08.006.
   PubMed Web of Science ®Google Scholar
• Beitland S, Platou E, Sunde K. 2014. Drug‐induced long QT syndrome and fatal arrhythmias in the intensive care unit. Acta Anaesth Scand. 58:266–272. doi: 10.1111/aas.12257.
   PubMed Web of Science ®Google Scholar
• Biermann J, Wu K, Odening KE, Asbach S, Koren G, Peng X, Zehender M, Bode C, Brunner M. 2011. Nicorandil normalizes prolonged repolarisation in the first transgenic rabbit model with long-QT syndrome 1 both in vitro and in vivo. Eur J Pharmacol. 650:309–316. doi: 10.1016/j.ejphar.2010.10.016.
   PubMed Web of Science ®Google Scholar
• Bruggeman C, O’Day CS. 2021. Selective serotonin reuptake inhibitor toxicity. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL. https://www.ncbi.nlm.nih.gov/books/NBK534815.
   Google Scholar
• Büyükdeligöz M, Hocaoğlu N, Oransay K, Tunçok Y, Kalkan Ş. 2015. The effects of the adenosine receptor antagonists on the reverse of cardiovascular toxic effects induced by citalopram in-vivo rat model of poisoning. Balk Med J. 32:303–308. doi: 10.5152/balkanmedj.2015.15932.
   PubMed Web of Science ®Google Scholar
• Cecen E, Dost T, Culhaci N, Karul A, Ergur B, Birincioglu M. 2011. Protective effects of silymarin against doxorubicin-induced toxicity. Asian Pac J Cancer Preven. 12:2697–2704.
   PubMed Web of Science ®Google Scholar
• Elie D, Noohi S, Do A, Mahdanian A, Yu C, Segal M, Looper KJ, Rej S. 2016. Citalopram and escitalopram: adverse cardiac outcomes in medically ill inpatients. Ther Adv Drug Saf. 7:225–226. doi: 10.1177/2042098616660947.
   PubMedGoogle Scholar
• Fayssoil A, Issi J, Guerbaa M, Raynaud JC, Heroguelle V. 2011. Torsade de pointes induced by citalopram and amiodarone. Ann Cardiol Angeiol (Paris). 60:165–168. doi: 10.1016/j.ancard.2010.12.002.
   PubMed Web of Science ®Google Scholar
• Grundemar L, Wohlfart B, Lagerstedt C, Bengtsson F, Eklundh G. 1997. Symptoms and signs of severe citalopram overdose. Lancet. 349:1602. doi: 10.1016/S0140-6736(05)61630-3.
   PubMed Web of Science ®Google Scholar
• Horinaka S. 2011. Use of nicorandil in cardiovascular disease and its optimization. Drugs. 71:1105–1119. doi: 10.2165/11592300-000000000-00000.
   PubMed Web of Science ®Google Scholar
• Horinaka S, Kobayashi N, Higashi T, Hara K, Hara S, Matsuoka H. 2001. Nicorandil enhances cardiac endothelial nitric oxide synthase expression via activation of adenosine triphosphate-sensitive K channel in rat. J Cardiovasc Pharmacol. 38:200–210. doi: 10.1097/00005344-200108000-00005.
   PubMed Web of Science ®Google Scholar
• Hothi SS, Booth SW, Sabir IN, Killeen MJ, Simpson F, Zhang Y, Grace AA, Huang C-H. 2008. Arrhythmogenic substrate and its modification by nicorandil in a murine model of long QT type 3 syndrome. Prog Biophys Mol Biol. 98:267–280. doi: 10.1016/j.pbiomolbio.2009.01.006.
   PubMed Web of Science ®Google Scholar
• Ilgin S, Kilic G, Baysal M, Kilic V, Korkut B, Ucarcan S, Atli O. 2017. Citalopram induces reproductive toxicity in male rats. Birth Def Res. 109:475–485. doi: 10.1002/bdr2.1010.
   PubMedGoogle Scholar
• Isbister GK, Bowe SJ, Dawson A, Whyte IM. 2004. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol. 42:277–285. doi: 10.1081/CLT-120037428.
   PubMed Web of Science ®Google Scholar
• Khan IA, Gowda RM. 2004. Novel therapeutics for treatment of long-QT syndrome and torsade de pointes. Int J Cardiol. 95:1–6. doi: 10.1016/j.ijcard.2003.04.018.
   PubMed Web of Science ®Google Scholar
• Kraai EP, Seifert SA. 2015. Citalopram overdose: a fatal case. J Med Toxicol. 11:232–236. doi: 10.1007/s13181-014-0441-0.
   PubMed Web of Science ®Google Scholar
• Lu H, Vlaminckx E, Hermans A, Rohrbacher J, Van Ammel K, Towart R, Pugsley M, Gallacher D. 2008. Predicting drug‐induced changes in QT interval and arrhythmias: QT‐shortening drugs point to gaps in the ICHS7B guidelines. Br J Pharmacol. 154:1427–1438. doi: 10.1038/bjp.2008.191.
   PubMed Web of Science ®Google Scholar
• Lu HR, Yu F, Dai DZ, Remeysen P, De Clerck F. 1999. Reduction in QT dispersion and ventricular arrhythmias by ischaemic preconditioning in anaesthetized, normotensive and spontaneously hypertensive rats. Fund Clin Pharmacol. 13:445–454. doi: 10.1111/j.1472-8206.1999.tb00002.x.
   PubMed Web of Science ®Google Scholar
• Mannhold R. 2004. KATP channel openers: structure‐activity relationships and therapeutic potential. Med Res Rev. 24:213–266. doi: 10.1002/med.10060.
   PubMed Web of Science ®Google Scholar
• Nishikawa S, Tatsumi T, Shiraishi J, Matsunaga S, Takeda M, Mano A, Kobara M, Keira N, Okigaki M, Takahashi T. 2006. Nicorandil regulates Bcl-2 family proteins and protects cardiac myocytes against hypoxia-induced apoptosis. J Mol Cell Cardiol. 40:510–519. doi: 10.1016/j.yjmcc.2006.01.020.
   PubMed Web of Science ®Google Scholar
• Oransay K, Hocaoglu N, Buyukdeligoz M, Tuncok Y, Kalkan S. 2014. The role of adenosine receptors and endogenous adenosine in citalopram-induced cardiovascular toxicity. Ind J Pharmacol. 46:378–385. doi: 10.4103/0253-7613.135948.
   Google Scholar
• Ozel F, Kiray M, Goker A, Aydemir S, Micili SC. 2020. Protective effect of alpha lipoic acid on 4-vinylcyclohexene diepoxide induced primary ovarian failure in female rats. Tai J Obstet Gynecol. 59:293–300. doi: 10.1016/j.tjog.2020.01.020.
   PubMed Web of Science ®Google Scholar
• Patel N, Wiśniowska B, Jamei M, Polak S. 2018. Real patient and its virtual twin: application of quantitative systems toxicology modelling in the cardiac safety assessment of citalopram. Am Assoc Pharmaceut Sci J. 20:1–10. doi: 10.1208/s12248-017-0155-8.
   Google Scholar
• Polat I, Micili SC, Calisir M, Bayram E, Yis U, Ayanoglu M, Okur D, Edem P, Paketci C, Tugyan K, Yilmaz O, Kurul SH. 2020. Neuroprotective effects of lacosamide and memantine on hyperoxic brain ınjury in rats. Neurochem Res. 45:1920–1929. doi: 10.1007/s11064-020-03056-5.
   PubMed Web of Science ®Google Scholar
• Refaie MM, Shehata S, El-Hussieny M, Abdelraheem WM, Bayoumi AM. 2020. Role of ATP-sensitive potassium channel (KATP) and eNOS in mediating the protective effect of nicorandil in cyclophosphamide-induced cardiotoxicity. Cardiovasc Toxicol. 20:71–81. doi: 10.1007/s12012-019-09535-8.
   PubMed Web of Science ®Google Scholar
• Sasaki N, Sato T, Ohler A, O’Rourke B, Marbán E. 2000. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation. 101:439–445. doi: 10.1161/01.CIR.101.4.439.
   PubMed Web of Science ®Google Scholar
• Schult RF, Morris AJ, Picard L, Wiegand TJ. 2019. Citalopram overdose and severe serotonin syndrome in an intermediate metabolizing patient. Am J Emer Med. 37:1993.e5–1993.e6. doi: 10.1016/j.ajem.2019.06.038.
   Web of Science ®Google Scholar
• Shah SR, Park K, Alweis R. 2019. Long QT syndrome: a comprehensive review of the literature and current evidence. Curr Prob Cardiol. 44:92–106. doi: 10.1016/j.cpcardiol.2018.04.002.
   PubMed Web of Science ®Google Scholar
• Shimizu W, Antzelevitch C. 1998. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of β-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation. 98:2314–2322. doi: 10.1161/01.CIR.98.21.2314.
   PubMed Web of Science ®Google Scholar
• Shimizu W, Antzelevitch C. 2000. Effects of a K+ channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome. Circulation. 102:706–712. doi: 10.1161/01.CIR.102.6.706.
   PubMed Web of Science ®Google Scholar
• Su Q, Li L, Zhao J, Sun Y, Yang H. 2017. Effects of nicorandil on PI3K/Akt signaling pathway and its anti-apoptotic mechanisms in coronary microembolization in rats. Oncotarget. 8:99347–99358. doi: 10.18632/oncotarget.19966.
   PubMedGoogle Scholar
• Takahashi N, Ito M, Saikawa T, Arita M. 1991. Nicorandil suppresses early afterdepolarisation and ventricular arrhythmias induced by caesium chloride in rabbits in vivo. Cardiovasc Res. 25:445–452. doi: 10.1093/cvr/25.6.445.
   PubMed Web of Science ®Google Scholar
• Tampi RR, Balderas M, Carter KV, Tampi DJ, Moca M, Knudsen A, May J. 2015. Citalopram, QTc prolongation, and torsades de pointes. Psychosomatics. 56:36–43. doi: 10.1016/j.psym.2014.09.002.
   PubMed Web of Science ®Google Scholar
• Tan Y, Duan J, Li Y, Cai W. 2010. Effects of citalopram on serum deprivation induced PC12 cell apoptosis and BDNF expression. Pharm Int J Pharmaceut Sci. 65:845–848.
   Google Scholar
• Thomas SH, Behr ER. 2016. Pharmacological treatment of acquired QT prolongation and torsades de pointes. Br J Clin Pharmacol. 81:420–427. doi: 10.1111/bcp.12726.
   PubMed Web of Science ®Google Scholar
• Tinker A, Aziz Q, Li Y, Specterman M. 2011. ATP‐sensitive potassium channels and their physiological and pathophysiological roles. Comp Physiol. 8:1463–1511.
   Google Scholar
• Tsutsui H, Kinugawa S, Matsushima S. 2011. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol. 301:H2181–H2190. doi: 10.1152/ajpheart.00554.2011.
   PubMed Web of Science ®Google Scholar
• Ueda H, Hayashi T, Tsumura K, Yoshimaru K, Nakayama Y, Yoshikawa J. 2004a. Intravenous nicorandil can reduce QT dispersion and prevent bradyarrhythmia during percutaneous transluminal coronary angioplasty of the right coronary artery. J Cardiovasc Pharmacol Ther. 9:179–184. doi: 10.1177/107424840400900305.
   PubMed Web of Science ®Google Scholar
• Ueda H, Nakayama Y, Tsumura K, Yoshimaru K, Hayashi T, Yoshikawa J. 2004b. Intravenous nicorandil can reduce the occurrence of ventricular fibrillation and QT dispersion in patients with successful coronary angioplasty in acute myocardial infarction. Can J Cardiol. 20:625–629
   PubMed Web of Science ®Google Scholar
• Van Noord C, Eijgelsheim M, Stricker BHC. 2010. Drug‐and non‐drug‐associated QT interval prolongation. Br J Clin Pharmacol. 70:16–23. doi: 10.1111/j.1365-2125.2010.03660.x.
   PubMed Web of Science ®Google Scholar
• Wang A, Chen F, Xie Y, Guo Z, Yu Y. 2012. Protective mechanism of nicorandil on rat myocardial ischemia-reperfusion. J Cardiovasc Med. 13:511–515. doi: 10.2459/JCM.0b013e3283542031.
   Google Scholar
• Wang M, Szepietowska B, Polonsky B, McNitt S, Moss AJ, Zareba W, Auerbach DS. 2018. Risk of cardiac events associated with antidepressant therapy in patients with long QT syndrome. Am J Cardiol. 121:182–187. doi: 10.1016/j.amjcard.2017.10.010.
   PubMed Web of Science ®Google Scholar
• Watanabe I, Okumura Y, Ohkubo K, Nagashima K, Mano H, Sonoda K, Kofune M, Kunimoto S, Kasamaki Y, Hirayama A. 2011. Effect of the ATP-sensitive K+ channel opener nicorandil in a canine model of proarrhythmia. Int Heart J. 52:318–322. doi: 10.1536/ihj.52.318.
   PubMed Web of Science ®Google Scholar
• Wei J, Watanabe Y, Takeuchi K, Yamashita K, Tashiro M, Kita S, Iwamoto T, Watanabe H, Kimura J. 2016. Nicorandil stimulates a Na+/Ca 2+ exchanger by activating guanylate cyclase in guinea pig cardiac myocytes. Pflügers Arch Eur J Physiol. 468:693–703. doi: 10.1007/s00424-015-1763-8.
   PubMed Web of Science ®Google Scholar
• Xia Z, Depierre JW, Nässberger L. 1996. The tricyclic antidepressants clomipramine and citalopram induce apoptosis in cultured human lymphocytes. J Pharm Pharmacol. 48:115–116. doi: 10.1111/j.2042-7158.1996.tb05889.x.
   PubMed Web of Science ®Google Scholar
• Xia Z, Bergstrand A, DePierre JW, Nässberger L. 1999. The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL‐60 cells via caspase‐3 activation. J Biochem Mol Toxicol. 13:338–347. doi: 10.1002/(SICI)1099-0461(1999)13:6<338:AID-JBT8>3.0.CO;2-7.
   PubMed Web of Science ®Google Scholar
• Yang Z, Shi G, Li C, Wang H, Liu K, Liu Y. 2004. Electrophysiologic effects of nicorandil on the guinea pig long QT1 syndrome model. J Cardiovasc Electrophysiol. 15:815–820. doi: 10.1046/j.1540-8167.2004.03632.x.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhang H, Liu C, Li X, Ling M, Wang Z, Xing Y. 2018. Myocardial protective effects of nicorandil on rats with type 2 diabetic cardiomyopathy. Med Sci Monit Basic Res. 24:141–145. doi: 10.12659/MSMBR.910974.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Baranchuk A, Hancox JC. 2014. Towards limiting QT interval prolongation and arrhythmia risk in citalopram use. Cardiol J. 21:454–457. doi: 10.5603/CJ.2014.0076.
   PubMed Web of Science ®Google Scholar